VR Logo

Dr. Lal Pathlabs: Board to consider Q1 Results & Interim Dividend on July 28 2022

Dr. Lal PathLabs Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on July 28 2022 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2022 and to consider the proposal of declaration of interim dividend if any on the Equity Shares of the Company for the Financial Year 2022-23.

Click here to view PDF